Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
drug metabolite |
| gptkbp:CASNumber |
86541-74-4
|
| gptkbp:drugClass |
ACE inhibitor
|
| gptkbp:excretion |
gptkb:kidney
bile |
| gptkbp:foundIn |
human blood after benazepril administration
|
| gptkbp:hasMolecularFormula |
C17H22N2O4
|
| https://www.w3.org/2000/01/rdf-schema#label |
benazeprilat
|
| gptkbp:is_active_metabolite_of |
gptkb:benazepril
|
| gptkbp:is_administered_as |
benazepril (prodrug)
|
| gptkbp:IUPACName |
(3S,4S)-1-[(2S)-2-[(1S)-1-ethoxycarbonyl-3-phenylpropylamino]propanoyl]-4-phenylpiperazine-3-carboxylic acid
|
| gptkbp:mechanismOfAction |
inhibits angiotensin-converting enzyme (ACE)
|
| gptkbp:molecularWeight |
318.37 g/mol
|
| gptkbp:usedFor |
heart failure
hypertension |
| gptkbp:bfsParent |
gptkb:benazepril
|
| gptkbp:bfsLayer |
6
|